June 30, 2009

CDC recommendations IGRA (provisional)


Link here

IGRA is preferred for testing persons from groups that historically have poor rates of return for TST reading
IGRA is preferred for testing persons who have received BCG (as a vaccine or for cancer therapy)
TST is preferred for testing children younger than 5 years of age
IGRAs may be used in place of TST (without preference) to test recent contacts of persons with infectious tuberculosis with special considerations for follow-up testing
- Negative results prior to 8 wks typically should be confirmed by repeating the test 8–10 weeks after the end of exposure
- Repeating same test minimizes misclassification due to test discordance
IGRAs may be used in place of TST (without preference) for periodic screening to address occupational exposure to TB with special considerations regarding conversions and reversions